Down-regulation of connexin43 and connexin32 in keratocystic odontogenic tumours: Potential association with clinical features

Histopathology

Volumn 66, Issue 6, 2015, Pages 798-807

  Zhong, Wen Qun ^a   Chen, Gang ^a   Zhang, Wei ^a   Xiong, Xue Peng ^a   Ren, Jian Gang ^a   Zhao, Yi ^a   Liu, Bing ^a   Zhao, Yi Fang ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Connexin; Keratocystic odontogenic tumour; Proliferation

Indexed keywords

CONNEXIN 32; CONNEXIN 43; CYCLIN D1; CYCLINE; PROTEIN BCL 2; GAP JUNCTION PROTEIN; GJA1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; AUTOPHAGY; B CELL LYMPHOMA; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; DOWN REGULATION; FEMALE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LIGHT CHAIN; MALE; NUCLEOTIDE SEQUENCE; ODONTOGENIC KERATOCYST; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; APOPTOSIS; BIOSYNTHESIS; CLUSTER ANALYSIS; METABOLISM; ODONTOGENIC CYST; ODONTOGENIC TUMOR; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; AUTOPHAGY; BIOMARKERS, TUMOR; CLUSTER ANALYSIS; CONNEXIN 43; CONNEXINS; DOWN-REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; ODONTOGENIC CYSTS; ODONTOGENIC TUMORS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84927041446     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12569     Document Type: Article

References (36)

1. Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J. 2006; 85; 74.
2. Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncol. 2009; 45; 706-711.
3. Li RF, Chen G, Zhao Y, Zhao YF, Liu B. Increased expression of autophagy-related proteins in keratocystic odontogenic tumours: its possible association with growth potential. Br. J. Oral Maxillofac. Surg. 2014; 52; 551-556.
4. Mendes RA, Carvalho JF, van der Waal I. Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features. Oral Oncol. 2010; 46; 219-225.
5. Pazdera J, Kolar Z, Zboril V, Tvrdy P, Pink R. Odontogenic keratocysts/keratocystic odontogenic tumours: biological characteristics, clinical manifestation and treatment. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 2012; 158; 170-174.
6. Seyedmajidi M, Nafarzadeh S, Siadati S, Shafaee S, Bijani A, Keshmiri N. p53 and PCNA expression in keratocystic odontogenic tumors compared with selected odontogenic cysts. Int. J. Mol. Cell Med. 2013; 2; 185-193.
7. Carette D, Gilleron J, Chevallier D, Segretain D, Pointis G. Connexin a check-point component of cell apoptosis in normal and physiopathological conditions. Biochimie 2014; 101C; 1-9.
8. Naus CC, Laird DW. Implications and challenges of connexin connections to cancer. Nat. Rev. Cancer 2010; 10; 435-441.
9. Su V, Lau AF. Connexins: mechanisms regulating protein levels and intercellular communication. FEBS Lett. 2014; 588; 1212-1220.
10. Vinken M, Vanhaecke T, Papeleu P, Snykers S, Henkens T, Rogiers V. Connexins and their channels in cell growth and cell death. Cell. Signal. 2006; 18; 592-600.
11. McLachlan E, Shao Q, Wang HL, Langlois S, Laird DW. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res. 2006; 66; 9886-9894.
12. Sirnes S, Lind GE, Bruun J et al. Connexins in colorectal cancer pathogenesis. Int. J. Cancer 2014; doi: 10.1002/ijc.28911. [E-pub ahead of print].
13. Czyz J, Szpak K, Madeja Z. The role of connexins in prostate cancer promotion and progression. Nat. Rev. Urol. 2012; 9; 274-282.
14. Chen G, Zhang W, Li YP et al. Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma? Cardiovasc. Res. 2013; 98; 437-448.
15. Ritter CS, Finch JL, Slatopolsky EA, Brown AJ. Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int. 2001; 60; 1737-1744.
16. Chang CM, Wu TJ, Zhou S et al. Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation 2001; 103; 22-25.
17. Prasad K, Prabhu GK. Image analysis tools for evaluation of microscopic views of immunohistochemically stained specimen in medical research - review. J. Med. Syst. 2012; 36; 2621-2631.
18. Wang-Tilz Y, Tilz C, Wang B, Tilz GP, Stefan H. Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy. Epilepsia 2006; 47; 233-239.
19. Ren JG, Chen G, Zhu JY et al. Down-regulation of the TGF-beta/CCN2 signaling pathway in venous malformations: its target potential for sclerotherapy. Br. J. Dermatol. 2014; 171; 242-251.
20. Wittliff JL, Kruer TL, Andres A, Smolenkova I. Molecular signatures of estrogen receptor-associated genes in breast cancer predict clinical outcome. Adv. Exp. Med. Biol. 2008; 617; 349-357.
21. Zhang W, Chen G, Ren JG, Zhao YF. Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations. Br. J. Pharmacol. 2013; 170; 1210-1220.
22. Farnsworth NL, Benninger RK. New insights into the role of connexins in pancreatic islet function and diabetes. FEBS Lett. 2014; 588; 1278-1287.
23. Wei CJ, Xu X, Lo CW. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 2004; 20; 811-838.
24. Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M. Gap junctions and cancer: new functions for an old story. Antioxid. Redox Signal. 2009; 11; 323-338.
25. Kawasaki Y, Omori Y, Li Q et al. Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal. Int. J. Cancer 2011; 128; 51-62.
26. Villares GJ, Dobroff AS, Wang H et al. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Res. 2009; 69; 6730-6737.
27. Talbot J, Brion R, Picarda G et al. Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis. Biochim. Biophys. Acta 2013; 1832; 553-564.
28. Zhang YW, Kaneda M, Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J. Biol. Chem. 2003; 278; 44852-44856.
29. King TJ, Lampe PD. The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res. 2004; 64; 7191-7196.
30. Falk MM, Baker SM, Gumpert AM, Segretain D, Buckheit RW III. Gap junction turnover is achieved by the internalization of small endocytic double-membrane vesicles. Mol. Biol. Cell 2009; 20; 3342-3352.
31. Gaietta G, Deerinck TJ, Adams SR et al. Multicolor and electron microscopic imaging of connexin trafficking. Science 2002; 296; 503-507.
32. Su V, Cochrane K, Lau AF. Degradation of connexins through the proteasomal, endolysosomal and phagolysosomal pathways. J. Membr. Biol. 2012; 245; 389-400.
33. Lichtenstein A, Minogue PJ, Beyer EC, Berthoud VM. Autophagy: a pathway that contributes to connexin degradation. J. Cell Sci. 2011; 124; 910-920.
34. Bejarano E, Girao H, Yuste A et al. Autophagy modulates dynamics of connexins at the plasma membrane in a ubiquitin-dependent manner. Mol. Biol. Cell 2012; 23; 2156-2169.
35. Fong JT, Kells RM, Gumpert AM, Marzillier JY, Davidson MW, Falk MM. Internalized gap junctions are degraded by autophagy. Autophagy 2012; 8; 794-811.
36. Falk MM, Kells RM, Berthoud VM. Degradation of connexins and gap junctions. FEBS Lett. 2014; 588; 1221-1229.